17.000
+0,00%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -15.1% | +341.3% | 2 / 3 | +2.5% | +1.87 pp | -1.20 pp | +18.4% | 0.39 | 6.04 | 1.436 | +2,5% | 139 | −8,8% | 6.04 | 15.66 | −61,4% |
| Pts | 0 | 12 | 8 | 0 | 8 | 4 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 17.000 (close price on 2026-10-19)EPS (TTM): 2.814
Financial charts
1.Revenue & growth
VND bn1.436Q2/26
1.Revenue & growth
VND bn1.436Q2/26
2.Profit & growth
VND bn121Q2/26
3.Profit mix (Penman)
VND bn768Q2/26
4.Margins & cost structure
%10.3%Q2/26
5.Returns & cash cycle
% · days3.7%Q2/26
6.Earnings quality & cash
VND bn478Q2/26
7.Asset structure
VND bn7.865Q2/26
8.Funding & debt health
VND bn · times7.865Q2/26
9.Revenue backlog
VND bn63,8Q2/26
10.Valuation
times · %6,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %509Q2/26
Adjusted EPS growth, latest quarter
-15.1%
Average adjusted EPS growth, 3 quarters
341%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26